6.140USD-3.91%Mkt Cap: 43.13M USDP/E: —Last update: 2026-05-26
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally …
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap43.13M USD
Enterprise Value65.65M USD
Revenue (TTM)71.00K USD
Gross Profit-147.00K USD
Net Income (TTM)401.00K USD
Revenue/Share0.1060 USD
Last Price6.140 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees41
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.32
PEG—
EV/EBITDA-3.02
EV/Revenue924.59
P/S640.28
P/B0.63
EPS (TTM)-48.31
EPS (Forward)-2.74
52W Range
6.0001% of range28.44
52W High28.44 USD
52W Low6.000 USD
Profitability
Gross Margin-207.04%
Oper. Margin-13082.69%
EBITDA Margin0.00%
Profit Margin564.79%
ROE1.18%
ROA1.03%
Growth
Revenue Growth420.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.21M USD
CapEx (TTM)31.00K USD
FCF Margin-19715.32%
FCF Yield-32.45%
Net Debt11.40M USD
Net Debt/EBITDA-0.53
Balance Sheet
Debt/Equity0.39
Current Ratio0.17
Quick Ratio0.13
Book Value/Sh10.01 USD
Cash/Share0.3090 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateJan 2, 2026
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)40.50 USD
Target Range16.00 USD – 65.00 USD
# Analysts2
Ownership
Shares Out.7.16M
Float1.67M
Insiders42.69%
Institutions9.92%
Short Interest
Short Ratio1.3d
Short % Float0.33%
Short % Out.0.24%
Shares Short17.72K
Short (prev mo.)23.48K
Technical
SMA 508.714 (-29.5%)
SMA 20010.62 (-42.2%)
Beta0.64
S&P 52W Chg28.31%
Avg Vol (30d)14.14K
Avg Vol (10d)15.47K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—